Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The International Medical University and IndiPharm (M) Collaborate to Provide Clinical Research Training and Education
  • USA - English


News provided by

General Manager Asia, Indipharm (M)

Aug 20, 2015, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Kuala Lumpur, MY (PRWEB) August 20, 2015 -- A Memorandum of Understanding (MoU) was signed between the International Medical University (IMU) and IndiPharm at the Putra World Trade Centre, Kuala Lumpur today in conjunction with the BioMalaysia Conference 2015. The exchange of MoU was witnessed by Yang Berhormat Datuk Wilfred Madius Tangau, Minister of Science, Technology and Innovation and Yang Berhormat Dato’ Sri Ahmad Shabery bin Cheek, Minister of Agriculture and Agro-based Industry.

We believe the training programmes we plan to implement are greatly needed, and will further propel Malaysia into a leadership position for clinical development in ASEAN

Post this

The MoU reaffirms the commitment of IMU and IndiPharm to provide high quality and customised research training programmes to clinical staff engaged in the conduct of clinical trials. Through the programmes, both public and private sector personnel involved in the managing/monitoring of clinical research activities will be able to achieve a heightened level of work readiness, resulting in an increase in the number of clinical trials that can be conducted in Malaysia and ASEAN.

IMU’s Institute of Research, Development and Innovation (IRDI) will be in charge of this training programme with IndiPharm. This is in line with IRDI’s role which include providing research directions, research management and oversight, consultancy and services to various stakeholders.

“This collaboration complements IMU’s aspiration to be the leader in healthcare education. In addition to our existing healthcare programmes, we are excited to work with IndiPharm to train and enhance the skills of the workforce in clinical research management,” said Tan Sri Dato’ Dr Abu Bakar Suleiman, President, IMU.

This strategic collaboration will tap into IndiPharm’s extensive network and experience in the field of clinical research training. Mr. Jeffrey Scott Yablon, Vice President, Business Development & General Manager Asia, IndiPharm acknowledged the importance of creating differentiated training programmes for practical clinical research management and work readiness and added “We believe the training programmes we plan to implement are greatly needed, and will further propel Malaysia into a leadership position for clinical development in ASEAN.”

This concerted effort is in line with the government’s Economic Transformation Programme, which aims to create a supportive ecosystem to grow clinical research in Malaysia.

Public and private sectors interested in knowing more on this training programme are invited to join the IRDI’s Industry Talk on Clinical Research Training that will be held in October at the IMU Bukit Jalil campus.

For more information on the industry talk, please contact Ms. Lai Pei Kuan of IRDI, IMU at tel: +603-27317044 or email: irdi(AT)imu.edu.my

About International Medical University (IMU)
International Medical University (IMU) is Malaysia’s first and most established private medical and health sciences university with over 20 years of dedicated focus in healthcare education. Established in 1992, IMU pioneered the world’s first Partner Medical School programme and has since gained international recognition with over 30 world class university partners in Australia, New Zealand, United Kingdom, Canada, US, Ireland and China. IMU’s main campus is located at Bukit Jalil, Kuala Lumpur with branch clinical schools located in Seremban, Kuala Pilah, Batu Pahat and Kluang.

Committed to its brand promise, “Delivering the Future of Better Healthcare”, in 2010, IMU became be a fully integrated healthcare institution offering Education, Healthcare services in both medical and complimentary alternative medicine and Research to serve and improve the quality of lives.

IMU’s Institute of Research, Development and Innovation (IRDI)
IRDI is guided by a Joint Committee on Research and Ethics (IMU-JC) which consists of representatives from different fields including those from legal profession and religious group to evaluate research proposals. The IMU-JC has obtained accreditation from the National Pharmaceutical Control Bureau (NPCB), MOH to serve as one of the national Institutional Review Boards (IRB) for biomedical research and clinical trials. The four thrust areas identified under IRDI’s research and development programme are environmental and population health, bioactive molecules and drug discovery, cancer and stem cell research, and health professional education research. Under IRDI’s purview are also the School of Postgraduate Studies and the Commercialisation and Support arm.

For more information on IMU, visit http://www.imu.edu.my

About IndiPharm
IndiPharm (Malaysia) is a division of IndiPharm Inc. IndiPharm is a clinical development organisation, headquartered in the United States, with clinical and administrative operations in Malaysia and India. IndiPharm’s experienced management team, U.S.-based client services, strong global SOPs, well-trained medical and professional staff, combined with a deep understanding of the local culture and regulatory system, facilitates the delivery of cost effective, high quality clinical development services.

For additional information on IndiPharm visit http://www.indipharm.com

Jeffrey Scott Yablon, General Manager Asia, Indipharm (M), +60 3 2615 7870, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.